去铁胺治疗眼部铁质沉着症：长期电生理评估
Desferrioxamine in ocular siderosis: a long-term electrophysiological evaluation.
作者信息
Declercq S S
出版信息
Br J Ophthalmol. 1980 Aug;64(8):626-9. doi: 10.1136/bjo.64.8.626.
Abstract
Fourteen rabbits received an intravitreal iron foreign body and were treated with desferrioxamine. Their electroretinographic (ERG) values were recorded and compared with those of an untreated group. With desferrioxamine treatment a delay of the siderotic damage and preservation of better ERG potentials is observed.
摘要
十四只兔子接受了玻璃体内铁异物植入，并接受去铁胺治疗。记录了它们的视网膜电图（ERG）值，并与未治疗组的进行比较。通过去铁胺治疗，观察到铁锈症损伤出现延迟，且视网膜电图电位得到了更好的保留。
相似文献
1
Desferrioxamine in ocular siderosis: a long-term electrophysiological evaluation.去铁胺治疗眼部铁质沉着症：长期电生理评估
Br J Ophthalmol. 1980 Aug;64(8):626-9. doi: 10.1136/bjo.64.8.626.
2
[Applications of a new chelating substance in ophthalmology. Therapeutic results in a case of ocular siderosis treated with desferrioxamine B].
Ann Ottalmol Clin Ocul. 1965 Jul;91(7):497-513.
3
Studies on the use of desferrioxamine in experimental ocular siderosis produced by extrabulbar administration of iron.
Graefes Arch Clin Exp Ophthalmol. 1985;223(2):101-5. doi: 10.1007/BF02150954.
4
[Treatment of ocular siderosis with desferrioxamine B].
Ann Ottalmol Clin Ocul. 1968 May;94(5):518-30.
5
[Clinical and experimental results of the treatment of some ocular diseases with desferrioxamine B].
Ann Ottalmol Clin Ocul. 1969 Mar;95(3):200-24.
6
Treatment of ocular siderosis and haemochromatosis with desferrioxamine.去铁胺治疗眼部铁质沉着症和血色素沉着症
Acta Ophthalmol (Copenh). 1966;44(1):95-9. doi: 10.1111/j.1755-3768.1966.tb06437.x.
7
[Absolute latency of a columinous intra-ocular foreign body; prognosis of local siderosis].[巨大眼内异物的绝对潜伏期；局部铁质沉着症的预后]
Arch Ophtalmol Rev Gen Ophtalmol. 1970 Aug-Sep;30(8):661-3.
8
Desferrioxamine B in ophthalmology. Applications and therapeutic possibilities.眼科中的去铁胺B。应用及治疗可能性。
Am J Ophthalmol. 1967 Jan;63(1):98-103. doi: 10.1016/0002-9394(67)90582-x.
9
[Clinical aspects of ocular siderosis].[眼铁质沉着症的临床方面]
Pol Tyg Lek. 1980 Aug 11;35(32):1229-30.
10
[Our experience with desferrioxamine B in the treatment of ocular siderosis (apropos of 6 cases)].
Bull Soc Ophtalmol Fr. 1966 Sep;66(9):774-81.
引用本文的文献
1
Iron: More than Meets the Eye.铁：超乎所见
Nutrients. 2025 Sep 16;17(18):2964. doi: 10.3390/nu17182964.
2
Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature.铁过载和铁螯合剂暴露与贫血相关性外层视网膜变性：病例报告及文献复习。
BMC Ophthalmol. 2021 Jul 13;21(1):277. doi: 10.1186/s12886-021-02030-1.
3
Studies on the use of desferrioxamine in experimental ocular siderosis produced by extrabulbar administration of iron.
Graefes Arch Clin Exp Ophthalmol. 1985;223(2):101-5. doi: 10.1007/BF02150954.
本文引用的文献
1
THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.去铁胺的生物化学及其与铁代谢的关系。
Ann N Y Acad Sci. 1964 Oct 7;119:758-68. doi: 10.1111/j.1749-6632.1965.tb54077.x.
2
Desferrioxamine B in ophthalmology. Applications and therapeutic possibilities.眼科中的去铁胺B。应用及治疗可能性。
Am J Ophthalmol. 1967 Jan;63(1):98-103. doi: 10.1016/0002-9394(67)90582-x.
3
Treatment of ocular siderosis and haemochromatosis with desferrioxamine.去铁胺治疗眼部铁质沉着症和血色素沉着症
Acta Ophthalmol (Copenh). 1966;44(1):95-9. doi: 10.1111/j.1755-3768.1966.tb06437.x.
4
Treatment of experimental siderosis bulbi, vitreous hemorrhage, and corneal blood staining with deferoxamine.
Arch Ophthalmol. 1966 May;75(5):698-707. doi: 10.1001/archopht.1966.00970050700023.
5
Long-term desferrioxamine therapy in thalassemia.
Ann N Y Acad Sci. 1974;232(0):201-10. doi: 10.1111/j.1749-6632.1974.tb20586.x.
6
Continuous subcutaneous administration of deferoxamine in patients with iron overload.
N Engl J Med. 1977 Aug 25;297(8):418-23. doi: 10.1056/NEJM197708252970804.
7
Experimental siderosis in the rabbit: correlation between electroretinography and histopathology.
Arch Ophthalmol. 1977 Jun;95(6):1051-8. doi: 10.1001/archopht.1977.04450060138014.
Zotero 插件